Journals / Archives of Basic and Clinical Research / 2022 / Cilt: 4 - Sayı: 2

Evaluation of Coronavirus PCR and Anti-Coronavirus Antibody Test Results: The First 4 Months of the Pandemic

Coronavirus PCR ve Anti-Coronavirus Antikor Test Sonuçlarının Değerlendirilmesi: Pandeminin İlk 4 Ayı

Pages
56–61
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need to closely monitor society’s immunity and carry out more comprehensive studies, including asymptomatic cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to evaluate the Coronavirus polymerase chain reaction test results sent to our laboratory and the anti Coronavirus antibody positivity in our region.
📊
Key Findings & Data:The polymerase chain reaction and enzyme-linked immunosorbent assay tests were screened within 4 months, and then the people who had both polymerase chain reaction and enzyme-linked immunosorbent assay tests were examined.
💡
Conclusion & Impact:There is a need to closely monitor society’s immunity and carry out more comprehensive studies, including asymptomatic cases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to evaluate the Coronavirus polymerase chain reaction test results sent to our laboratory and the anti Coronavirus antibody positivity in our region. Methods: Samples sent to our laboratory for Coronavirus poly merase chain reaction and anti-Coronavirus antibody tests were scanned retrospectively. The polymerase chain reaction and enzyme-linked immunosorbent assay tests were screened within 4 months, and then the people who had both polymerase chain reaction and enzyme-linked immunosorbent assay tests were examined. Results: Coronavirus polymerase chain reaction test was per formed on 31 162 people in 4 months. Of which, 794 (2.5%) of these people were found to be positive. The positivity rate in the first, second, third, and fourth months was 11.2%, 1.2%, 0.7%, and 1%, respectively. Enzyme-linked immunosorbent assay tests were studied from 1163 people over 4 months. Enzyme-linked immunosorbent assay test was found positive in 23 (1.98%) of these people. Conclusions: As a result, the number of COVID-19 cases could be brought under control in the first month due to our prov ince’s good cooperation between the laboratory and field teams. Anti-Coronavirus antibody level in the community was found below expected. There is a need to closely monitor society’s immunity and carry out more comprehensive studies, including asymptomatic cases.

Özet

Amaç: Çalışmamızda laboratuvarımıza gönderilen Coronavirus PCR test sonuçlarını ve bölgemizdeki anti-Coronavirus antikor pozitifliğini değerlendirmeyi amaçladık. Gereç ve Yöntemler: Laboratuvarımıza Coronavirus PCR ve anti-Coronavirus antikor testi çalışılması için gönderilen örnekler retrospektif olarak taranmıştır. 4 aylık süre içinde PCR ve ELISA testleri kendi içinde taranmış, daha sonra ise hem PCR hem de ELISA testi yapılan kişiler irdelenmiştir. Bulgular: Dört aylık sürede 31162 kişiye Coronavirus PCR testi yapılmıştır. Bu kişilerden 794’ü (%2,5) pozitif saptanmıştır. Birinci, ikinci, üçüncü ve dördüncü aydaki pozitiflik oranı sıra sıyla %11,2, %1,2, %0,7 ve %1 olarak bulunmuştur. Dört aylık sürede 1163 kişiden ELISA testi çalışılmıştır. Bu kişilerin 23’ünde (%1,98) ELISA testi pozitif bulunmuştur. Sonuç: Sonuç olarak ilimizde laboratuvar ile saha ekipleri ara sındaki işbirliğinin iyi olmasından dolayı ve ülke genelinde alınan tedbirlerin de etkisiyle COVID-19 vaka sayısı ilk ay içinde hızla kontrol altına alınabilmiştir. Toplumdaki anti-Coronavirus anti kor seviyesi beklenenin altında bulunmuştur. Bu anlamda top lumdaki bağışıklığın yakından takip edilmesi ve asemptomatik vakaları da içerecek şekilde daha kapsamlı çalışmalar yapmaya ihtiyaç vardır.

🔖

Cite This Article

DAVARCI, İ., ERYILDIZ, C., GÜRCAN, Ş., YILDIRIM, M. İ., CERİT, Ç. (2022). Evaluation of Coronavirus PCR and Anti-Coronavirus Antibody Test Results: The First 4 Months of the Pandemic. Archives of Basic and Clinical Research, Cilt: 4 - Sayı: 2, 56–61. https://ajindex.com/articles/648670

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. World Health Organization. Novel coronavirus – China. Available at: http://www.who.int/csr/don/12-january-20 20-novel-coronavirus-china/en/. Accessed March 3, 2021
  2. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA. The species severe acute respiratory syn drome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536-544. [CrossRef] 3. World Health Organization. Timeline: WHO’s COVID-19 response. Available at: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/interactive-timeline#. Accessed March 3, 2021
  3. World Health Organization. WHO coronavirus (COVID-19) dashboard. Available at: https://covid19.who.int. Accessed September 4, 2020
  4. World Health Organization. Diagnostic testing for SARS CoV-2: interim guidance; 2020. Available at: https://ww w.who.int/publications/i/item/diagnostic-testing-for-sa rs-cov-2. Accessed October 16, 2020
  5. International Committee on Taxonomy of Viruses (ICTV). Available at: https://talk.ictvonline.org/. Accessed July 27, 2020
  6. Muench P, Jochum S, Wenderoth V, et al. Development and validation of the Elecsys anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARS-CoV-2. J Clin Microbiol. 2020;58(10):e01694-2. [CrossRef] 8. Ni L, Ye F, Cheng ML, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971-977.e3. [CrossRef] 9. Jiang S, Hillyer C, Du L. Neutralising antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41(5):355-359. [CrossRef] 10. TC Sağlık Bakanlığı. COVID-19 Bilgilendirme Platformu. Available at: https://covid19.saglik.gov.tr/. Accessed Sep tember 5, 2020
  7. World Health Organization. Molecular assays to diagnose COVID-19: summary table of available protocols; 2020. Available at: https://www.who.int/publications/m/item/ molecular-assays-to-diagnose-covid-19-summary-tabl e-of-available-protocols. Accessed September 5, 2020
  8. To KK, Hung IF, Ip JD, et al. COVID-19 re-infection by a phy logenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020;73(9): e2952-e2959. [CrossRef]